Verified employee & interview reviews

Abbott India Reviews

Mumbai, Maharashtra

4.0/ 5

3 reviews

Abbott India Limited, established in 1910, is one of India's oldest, most admired, and fastest-growing healthcare companies. Headquartered in Mumbai, it operates as a publicly listed corporate entity and a key subsidiary of the global healthcare giant Abbott Laboratories, USA. The company is dedicated to helping people across India live healthier, more complete lives by delivering a diverse portfolio of science-based nutritional products, diagnostic tools, medical devices, and branded generic pharmaceuticals that span the entire continuum of care. The core operations of Abbott India are fundamentally anchored in its single reportable business segment: Pharmaceuticals. The company holds a position of market leadership by specializing in multiple critical therapeutic categories. These primary areas of medical focus include women's health, gastroenterology, cardiology, metabolic disorders, the central nervous system (CNS), hepatic care, vaccines, and multi-specialty care (covering areas like insomnia, vitamin D deficiency, pain management, and pre-term labor). Abbott India possesses expertise across the entire commercial lifecycle, including local product development, manufacturing, sales, and comprehensive customer service. To ensure its medicines match the unique healthcare requirements of the Indian demographic, its in-house medical teams actively undertake specialized product and clinical development tailored specifically for the domestic market. Abbott India distributes its vast commercial portfolio of over 400 trusted pharmaceutical brands primarily within India, leveraging an extensive commercial footprint that utilizes independent distributors, over 50,000 stockists, and approximately 500,000 pharmacies to reach patients in both urban and rural regions. While the company maintains advanced pharmaceutical manufacturing facilities in Verna, Goa, and Baddi, Himachal Pradesh, it relies on a strategic manufacturing model where it outsources a significant portion of its production, with roughly one-third of its total drugs manufactured in-house. Its popular commercial brands include widely recognized names such as Thyronorm, Digene, Cremaffin, Duphaston, Udiliv, Vertin, and Influvac. Financially, Abbott India Limited is publicly traded on the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker symbols ABBOTINDIA and 500488, respectively. Showing robust financial health, the company operates virtually debt-free and maintains high-yielding track records for Return on Capital Employed (ROCE) and Return on Equity (ROE). For the trailing twelve months concluding in early 2026, the company reported a robust revenue from operations of approximately INR 6,929 crore (approx. USD 784 million) alongside a consolidated net income of INR 1,552 crore (approx. USD 175 million). Led by Managing Director Kartik Rajendran and CFO Maithilee Mistry, the company employs over 3,600 personnel directly, while contributing extensively to regional economies through localized sourcing, dairy farmer infrastructure programs, and dedicated corporate social responsibility initiatives.